Pregled Article autora: "Banković, Jasna"
Prikaz rezultata 1-6 od 6
-
Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors
Dragoj, Miodrag; Jovanović Stojanov, Sofija; Pešić, Milica; Stanković, Tijana; Banković, Jasna; Sereti, Evangelia; Dimas, Konstantinos (Investigational New Drugs, 2017) -
Association of Overexpressed MYC Gene with Altered PHACTR3 and E2F4 Genes Contributes to Non-Small Cell Lung Carcinoma Pathogenesis
Dragoj, Miodrag; Banković, Jasna; Podolski-Renić, Ana; Stojković Burić, Sonja; Pešić, Milica; Tanić, Nikola; Stanković, Tijana (Journal of Medical Biochemistry, 2019) -
Decreased TSPAN14 Expression Contributes to NSCLC Progression
Jovanović, Mirna; Stanković, Tijana; Stojković Burić, Sonja; Banković, Jasna; Dinić, Jelena; Ljujić, Mila; Pešić, Milica; Dragoj, Miodrag (Basel : MDPI, 2022) -
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
Podolski-Renić, Ana; Banković, Jasna; Dinić, Jelena; Ríos-Luci, Carla; Fernandes, Miguel X.; Ortega, Nuria; Kovačević-Grujičić, Nataša; Martín, Víctor S.; Padrón, José M.; Pešić, Milica (European Journal of Pharmaceutical Sciences, 2017) -
Purine nucleoside analogs in the therapy of cancer and neuroinflammation
Savić, Danijela; Stanković, Tijana; Lavrnja, Irena; Podolski-Renić, Ana; Banković, Jasna; Peković, Sanja; Stojiljković, Mirjana; Rakić, Ljubisav; Ruždijić, Sabera; Pešić, Milica (Molecular inhibitors in targeted therapy, 2015) -
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
Dragoj, Miodrag; Milošević, Zorica; Banković, Jasna; Tanić, Nikola; Pešić, Milica; Stanković, Tijana (Cellular Oncology, 2017)